Renal function in gout: long-term treatment effects of febuxostat.
about
Four-week effects of allopurinol and febuxostat treatments on blood pressure and serum creatinine level in gouty men.African American patients with gout: efficacy and safety of febuxostat vs allopurinol.The efficacy and safety of febuxostat for urate lowering in gout patients ≥65 years of age.Reduced glomerular function and prevalence of gout: NHANES 2009-10Efficacy and safety of febuxostat in patients with hyperuricemia and gout.Safety and efficacy of oral febuxostat for treatment of HLA-B*5801-negative gout: a randomized, open-label, multicentre, allopurinol-controlled study.Novel drugs and intervention strategies for the treatment of chronic kidney disease.Uric Acid - key ingredient in the recipe for cardiorenal metabolic syndrome.The effect of febuxostat to prevent a further reduction in renal function of patients with hyperuricemia who have never had gout and are complicated by chronic kidney disease stage 3: study protocol for a multicenter randomized controlled study.Comparison of the Renoprotective Effect of Febuxostat for the Treatment of Hyperuricemia between Patients with and without Type 2 Diabetes Mellitus: A Retrospective Observational Study.Effect of pegloticase on renal function in patients with chronic kidney disease: a post hoc subgroup analysis of 2 randomized, placebo-controlled, phase 3 clinical trialsEffects of uric acid-lowering therapy on renal outcomes: a systematic review and meta-analysis.Urate reduction and renal preservation: what is the evidence?Febuxostat: drug review and update.Urate-lowering therapy: current options and future prospects for elderly patients with gout.Febuxostat: a review of its use in the treatment of hyperuricaemia in patients with gout.Febuxostat for the chronic management of hyperuricemia in patients with gout.Management of Gout and Hyperuricemia in CKD.The safety of treatment options available for gout.Glycosuria-mediated urinary uric acid excretion in patients with uncomplicated type 1 diabetes mellitus.Impact of Febuxostat on Renal Function in Gout Patients With Moderate-to-Severe Renal Impairment.Treatment of asymptomatic hyperuricemia in chronic kidney disease: A new target in an old enemy - A review.Serum uric acid and acute kidney injury: A mini review.Effect of Febuxostat, a Xanthine Oxidase Inhibitor, on Cardiovascular Risk in Hyperuricemic Patients with Hypertension: A Prospective, Open-label, Pilot Study.Febuxostat for hyperuricemia in patients with advanced chronic kidney diseasePreservation of renal function during gout treatment with febuxostat: a quantitative study.Tophaceous gout and renal insufficiency: a new solution for an old therapeutic dilemma.Febuxostat (Feburic tablet) in the management of hyperuricemia in a general practice cohort of Japanese patients with a high prevalence of cardiovascular problems.Effects of uric acid-lowering therapy in patients with chronic kidney disease: A meta-analysis.Recent pharmacological advances in the management of gout.The role of urate-lowering treatment on cardiovascular and renal disease: evidence from CARES, FAST, ALL-HEART, and FEATHER studies.Plasma uric acid effects on glomerular haemodynamic profile of patients with uncomplicated Type 1 diabetes mellitus.Febuxostat for treating allopurinol-resistant hyperuricemia in patients with chronic kidney disease.Improving adherence to gout therapy: an expert review.Efficacy and safety of febuxostat extended release and immediate release in patients with gout and moderate renal impairment: phase II placebo-controlled study.Langfassung zur S2e-Leitlinie Gichtarthritis (fachärztlich)
P2860
Q34029936-A396D747-40C2-4525-9D4E-F09BBF05DFC9Q34153554-6670827E-F0C3-4FEC-9CF4-7A24ED45732EQ34204854-8FCABBD0-9B41-4DF6-91D6-E342C021DE71Q34499903-3AD77A26-C0BC-4615-9EE5-78B9BFA39834Q36059557-F28F7FF1-7D47-4B9A-A6C3-559FBF7168AAQ36981450-9D3BCD51-0388-4FE5-96EE-A3BE8ED3E4E2Q37219043-8C2B2B3A-1F37-48F6-9367-A63749BB02C7Q37447055-129DE6ED-3066-48CD-84BA-9F47AF127808Q37506899-00060FC2-775E-4437-B11B-115044C2DE07Q37521108-678431F2-8B46-4280-B6EB-16FBCC017BA7Q37607659-8F1242E2-C0C8-4F26-B610-83C27F3A80D6Q38138322-91604F59-FA8C-4B44-86DE-EB4553509582Q38160768-C96B6D4E-0645-4FD6-8FDB-93DD8A0C147BQ38200657-33E3B8E1-8F06-4F34-A981-6FDF7E6E07E1Q38254304-657F437F-1A7F-482F-9CB5-EA95CA5D4CEAQ38365938-9CAF5FFD-A36F-4306-A8AB-C8EFDD24E438Q38760404-27AEB78B-AE2C-42C3-BCFE-0A14ED173632Q38812962-7D73AEF0-EDF1-460A-BEE9-5D6D588AF29FQ39092018-0818F2DD-4150-419D-9D4A-A5AC4BC44345Q39101749-DE54A70E-C764-4B7F-A951-A7B42B656D1AQ39984416-907F08F3-FF69-4886-8719-D6F5C95CB68BQ41026351-4FA79EAE-C536-42FC-B239-16C70422FD50Q41026374-5E81DB91-CDFE-4B80-A38E-3763DCFB2066Q41202631-5FC6658F-7F23-46D4-8415-3414598F0619Q42268534-0AD7B74E-FFCE-423D-B17B-724824F73783Q42686586-F1F63486-EF7E-4736-A6C2-355A391DFD68Q42737198-289A785A-B50C-4E5F-BAE1-5B07A481EB97Q43545502-B0667FB0-AF2A-43E3-B411-3C71B5EA7CC8Q47138528-C2EB0F53-3428-4AC3-860D-147097E83EC1Q47919692-131C1654-0BF8-4E6C-AECB-8F0FF96A8FE2Q49793137-3C370D0E-065D-4F41-B56C-F873DB387CC0Q50755126-E1407B02-C066-4DFC-A225-61F501B80A8BQ54464377-8F5919FE-1FF1-4425-9131-F9CE4B046964Q55220842-322C15EF-737A-4F79-B1F4-D1D5DE5AD589Q55284599-836DB0A0-816B-4FA3-8536-C87D7D70C9E5Q56637250-97B66811-4344-4327-8361-CB1BC5745237
P2860
Renal function in gout: long-term treatment effects of febuxostat.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Renal function in gout: long-term treatment effects of febuxostat.
@en
Renal function in gout: long-term treatment effects of febuxostat.
@nl
type
label
Renal function in gout: long-term treatment effects of febuxostat.
@en
Renal function in gout: long-term treatment effects of febuxostat.
@nl
prefLabel
Renal function in gout: long-term treatment effects of febuxostat.
@en
Renal function in gout: long-term treatment effects of febuxostat.
@nl
P2093
P1476
Renal function in gout: long-term treatment effects of febuxostat.
@en
P2093
Andrew Whelton
Barbara Hunt
Lhanoo Gunawardhana
Patricia A Macdonald
P356
10.1097/RHU.0B013E318204AAB4
P577
2011-01-01T00:00:00Z